Physician

Agnieszka Ewelina Mochon, MD

According to 2025 Medicare claims, Agnieszka Mochon, MD (NPI: 1851623896) practices cardiology in the Lancaster, PA market, with the plurality of this provider's patient population coming from Lancaster, PA. This provider's primary affiliated billing organization is WELLSPAN MEDICAL GROUP (NPI: 1972906667; TIN: 23-2730785) and primary practice location at 17522-1724. Mochon is affiliated with the WellSpan Population Health Services (ACO ID: A2500), participating under the MSSP model.

Mochon's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,425 traditional Medicare patients, billed 3,119 HCPCS/CPT codes, and received $116,812 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,625 prescription claims across 458 beneficiaries totaling $330,879 in drug costs, led by Eliquis (Apixaban). 2021 DME data shows 13 claims. Open Payments data shows 9 records totaling $209. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing started with an early spike, then settled into a lower baseline, moving from $322,050 to $116,812. In contrast, Part D prescription costs have risen steadily, from $69,208 to $330,879. For DME billing, reported payments moved up and down with repeated peaks and valleys, starting at $24,106 and ending at $29,598.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,071	4,550	$322,050
2016	1,703	3,251	$136,906
2017	2,039	3,781	$140,304
2018	1,950	3,610	$133,624
2019	1,488	2,741	$117,380
2020	1,342	2,421	$94,587
2021	1,765	3,069	$119,219
2022	1,443	2,544	$96,500
2023	1,287	2,890	$121,611
2024	1,425	3,119	$116,812

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	244	1,411	$69,208
2016	291	1,729	$123,023
2017	392	2,422	$223,243
2018	445	2,543	$277,333
2019	388	2,367	$298,216
2020	385	2,515	$343,473
2021	426	2,553	$588,827
2022	455	2,030	$367,609
2023	448	2,256	$346,058
2024	458	2,625	$330,879

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	12	$24,106
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	105	$15,046
2019	N/R	192	$22,888
2020	N/R	50	$4,498
2021	N/R	13	$28,142
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	186	241	$81
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	319	325	$58
93294	Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days	87	102	$19
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	287	319	$9
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	611	741	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	146	8,404	$158,004
Xarelto	Rivaroxaban	47	3,360	$58,984
Entresto	Sacubitril/Valsartan	32	1,482	$32,957
Jardiance	Empagliflozin	24	1,470	$28,117
Brilinta	Ticagrelor	14	870	$11,588

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	9	$209	ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Agnieszka Ewelina Mochon, MD?

Tedicare shows public-source Medicare data for Agnieszka Ewelina Mochon, MD (NPI 1851623896), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Agnieszka Ewelina Mochon, MD have ACO affiliation data?

Agnieszka Ewelina Mochon, MD is shown with ACO affiliation data for WellSpan Population Health Services (MSSP, ACO ID A2500).

What billing organization is linked to Agnieszka Ewelina Mochon, MD?

Agnieszka Ewelina Mochon, MD is linked to WELLSPAN MEDICAL GROUP (billing NPI 1972906667) in the available physician profile data.

Does Agnieszka Ewelina Mochon, MD have Open Payments data?

Agnieszka Ewelina Mochon, MD has 9 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.